Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Sustained Growth of Primary Myeloma Cells in Coculture with Whole Donor Bone Marrow Is Associated with Induced Secretion of the Microenvironmental Mediator of Cytokinesis, Hemicentin-1

Rakesh Bam, PhD, Ricky D Edmondson, PhD, Caleb K Stein, MS, Xin Li, PhD, Wen Ling, MS, Sharmin Khan, MS, Randal S Shelton, B.S., Bart Barlogie, MD, PhD, Shmuel Yaccoby, PhD

Blood (2014) 124 (21): 3403.

https://doi.org/10.1182/blood.V124.21.3403.3403

Published: 2014

Journal Articles

CYR61 /CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease

Sarah K. Johnson, James P. Stewart, Rakesh Bam, Pingping Qu, Bart Barlogie, Frits van Rhee, John D. Shaughnessy, Jr, Joshua Epstein, Shmuel Yaccoby

Blood (2014) 124 (13): 2051–2060.

https://doi.org/10.1182/blood-2014-02-555813

Published: 2014

Includes: Supplemental data

Journal Articles

Inhibition Of BTK Activity In Myeloma Cells Within a Supportive Microenvironment Promotes Their Growth But Suppresses Metastasis

Rakesh Bam, BS, Sathisha Upparahalli Venkateshaiah, Ph.D., Xin Li, PhD, Sharmin Khan, MS, Wen Ling, MS, Randal S Shelton, MS, Qing Zhang, PhD, Bart Barlogie, MD, PhD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD

Blood (2013) 122 (21): 4432.

https://doi.org/10.1182/blood.V122.21.4432.4432

Published: 2013

Journal Articles

Macrophages Activation By ICAM1 Antibody Combined With Lenalidomide Has Enhanced Anti-Myeloma Activity In a Supportive Microenvironment In Vivo and In Vitro

Sathisha Upparahalli Venkateshaiah, Ph.D., Rakesh Bam, BS, Xin Li, PhD, Khan Sharmin, MS, Ling Wen, MS, Randal S. Shelton, MS, Ingrid Teige, Björn Frendéus, Bart Barlogie, MD, PhD, Shmuel Yaccoby, PhD

Blood (2013) 122 (21): 1926.

https://doi.org/10.1182/blood.V122.21.1926.1926

Published: 2013

Journal Articles

GPRC5D Is a Cell Surface Plasma Cell Marker Whose Expression Is High In Myeloma Cells and Reduced Following Coculture With Osteoclasts

Sathisha Upparahalli venkateshaiah, PhD, Rakesh Bam, BS, Xin Li, PhD, Sharmin Khan, MS, Wen Ling, MS, Shelton Randal S, MS, Shmuel Yaccoby, PhD

Blood (2013) 122 (21): 3099.

https://doi.org/10.1182/blood.V122.21.3099.3099

Published: 2013

Journal Articles

Healthy Donor Whole Bone Marrow Cells Preconditioned With Myeloma Patient Serum Support Long-Term Survival Of Primary Myeloma and Reveal Altered Microenvironmental Pathways

Rakesh Bam, BS, Sathisha Upparahalli Venkateshaiah, Ph.D., Xin Li, PhD, Sharmin Khan, MS, Wen Ling, MS, Randal S Shelton, MS, Joshua Epstein, DSc, Bart Barlogie, MD, PhD, Shmuel Yaccoby, PhD

Blood (2013) 122 (21): 3118.

https://doi.org/10.1182/blood.V122.21.3118.3118

Published: 2013

Journal Articles

HMOX1 Is a Targeted Therapy for Myeloma-Induced Bone Disease.

Xin Li, PhD, Wen Ling, MS, Sharmin Khan, MS, Sathisha Upparahalli Venkateshaiah, PhD, Rakesh Bam, Bart Barlogie, MD, PhD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD

Blood (2012) 120 (21): 2944.

https://doi.org/10.1182/blood.V120.21.2944.2944

Published: 2012

Journal Articles

Upregulation of Lipid Metabolism Modulators in Myeloma Cells Underlines Their Progression in a Supportive Microenvironment and Linking Metabolic Pathways with Growth Signaling

Sathisha Upparahallivenkateshaiah, PhD, Khan Sharmin, MS, Ling Wen, MS, Rakesh Bam, Xin Li, PhD, Shmuel Yaccoby, PhD

Blood (2012) 120 (21): 329.

https://doi.org/10.1182/blood.V120.21.329.329

Published: 2012

Journal Articles

Deregulated Cellular Iron Metabolism Factors Mediate Iron Overload in Myeloma Cells and Osteoclasts, and Promote Myeloma Growth and Bone Disease,

Rakesh Bam, Wen Ling, MS, Sharmin Khan, MS, Sathisha Upparahalli Venkateshaiah, PhD, Xin Li, PhD, Frits van Rhee, MD, PhD, Bijay Nair, MD, Saad Usmani, MD, FACP, Bart Barlogie, MD, PhD, John D Shaughnessy, Jr., PhD, Joshua Epstein, DSc, Elias J. Anaissie, MD, Shmuel Yaccoby, PhD

Blood (2011) 118 (21): 3941.

https://doi.org/10.1182/blood.V118.21.3941.3941

Published: 2011

Journal Articles

Stearoyl CoA Desaturase 1 (SCD1) Is Upregulated in Rapidly Growing Myeloma Cells and Is Required for Cell Proliferation,

Sathisha Upparahalli Venkateshaiah, PhD, Sharmin Khan, MS, Wen Ling, MS, Linda Saint John, Rakesh Bam, Xin Li, PhD, Shmuel Yaccoby, PhD

Blood (2011) 118 (21): 3943.

https://doi.org/10.1182/blood.V118.21.3943.3943

Published: 2011

Journal Articles

Cell Surface CXCR4 and BTK Expression Are Associated in Myeloma Cells and Osteoclast Precursors and Mediate Myeloma Cell Homing and Clonogenicity, and Osteoclastogenesis

Rakesh Bam, Wen Ling, Sharmin Khan, Angela Pennisi, MD, Sathisha Upparahalli Venkateshaiah, PhD, Xin Li, PhD, Ryan Williams, Frits van Rhee, MD, PhD, Bijay Nair, MD, Saad Usmani, MD, FACP, Bart Barlogie, MD, PhD, John D Shaughnessy, Jr., PhD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD

Blood (2011) 118 (21): 884.

https://doi.org/10.1182/blood.V118.21.884.884

Published: 2011

Journal Articles

NAMPT/PBEF Enzymatic Activity Is Indispensable for Myeloma Cell Growth and Osteoclast Activity

Sathisha Upparahalli Venkateshaiah, PhD, Sharmin Khan, MS, Wen Ling, MS, Rakesh Bam, Xin Li, PhD, Bart Barlogie, MD, PhD, John D Shaughnessy, Jr., PhD, Shmuel Yaccoby, PhD

Blood (2011) 118 (21): 886.

https://doi.org/10.1182/blood.V118.21.886.886

Published: 2011

Journal Articles

Bruton's Tyrosine Kinase (BTK) Is Indispensable for Myeloma Cell Migration towards SDF-1 and Induction of Osteoclastogenesis and Osteolytic Bone Disease

Rakesh Bam, Angela Pennisi, MD, Xin Li, PhD, Sharmin Khan, MS, Yuping Wang, Ph.D., Wen Ling, MS, Bart Barlogie, M.D., Ph.D., John Shaughnessy, Jr., PhD, Shmuel Yaccoby, PhD

Blood (2010) 116 (21): 447.

https://doi.org/10.1182/blood.V116.21.447.447

Published: 2010

NARROW

Sustained Growth of Primary Myeloma Cells in Coculture with Whole Donor Bone Marrow Is Associated with Induced Secretion of the Microenvironmental Mediator of Cytokinesis, Hemicentin-1

CYR61 /CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease

Inhibition Of BTK Activity In Myeloma Cells Within a Supportive Microenvironment Promotes Their Growth But Suppresses Metastasis

Macrophages Activation By ICAM1 Antibody Combined With Lenalidomide Has Enhanced Anti-Myeloma Activity In a Supportive Microenvironment In Vivo and In Vitro

GPRC5D Is a Cell Surface Plasma Cell Marker Whose Expression Is High In Myeloma Cells and Reduced Following Coculture With Osteoclasts

Healthy Donor Whole Bone Marrow Cells Preconditioned With Myeloma Patient Serum Support Long-Term Survival Of Primary Myeloma and Reveal Altered Microenvironmental Pathways

HMOX1 Is a Targeted Therapy for Myeloma-Induced Bone Disease.

Upregulation of Lipid Metabolism Modulators in Myeloma Cells Underlines Their Progression in a Supportive Microenvironment and Linking Metabolic Pathways with Growth Signaling

Deregulated Cellular Iron Metabolism Factors Mediate Iron Overload in Myeloma Cells and Osteoclasts, and Promote Myeloma Growth and Bone Disease,

Stearoyl CoA Desaturase 1 (SCD1) Is Upregulated in Rapidly Growing Myeloma Cells and Is Required for Cell Proliferation,

Cell Surface CXCR4 and BTK Expression Are Associated in Myeloma Cells and Osteoclast Precursors and Mediate Myeloma Cell Homing and Clonogenicity, and Osteoclastogenesis

NAMPT/PBEF Enzymatic Activity Is Indispensable for Myeloma Cell Growth and Osteoclast Activity

Bruton's Tyrosine Kinase (BTK) Is Indispensable for Myeloma Cell Migration towards SDF-1 and Induction of Osteoclastogenesis and Osteolytic Bone Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only